Effects of antihypertensive drugs on antioxidant enzyme activities and renal function in stroke-prone spontaneously hypertensive rats

American Journal of the Medical Sciences

Volumn 314, Issue 6, 1997, Pages 377-384

  Shou, Ichiyu ^a   Wang, Li Ning ^a   Suzuki, Shigenobu ^a   Fukui, Mitsumine ^a   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin converting enzyme inhibitor; Antioxidant enzyme; Reactive oxygen species; Spontaneously hypertensive rat

Indexed keywords

ALBUMIN; CAPTOPRIL; CREATININE; GLUTATHIONE PEROXIDASE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; N ACETYL BETA GLUCOSAMINIDASE; RESERPINE; SUPEROXIDE DISMUTASE; TEMOCAPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; CREATININE CLEARANCE; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVITY; HYPERTENSION; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; PROTEIN URINE LEVEL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE;

EID: 0345451638     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199712000-00004     Document Type: Article

References (38)

1. Yazaki Y. Clinical approach to essential hypertension [in Japanese]. Saishiningaku. 1996;51(suppl)598-606.
2. Maki DD, Ma JZ, Louis TA, Kasiske BL. Long-term effects of antihypertensive agents on proteinuria and renal function. Arch Intern Med. 1995;155(10):1073-80.
3. Kutyrina IM, Tareeva IE, Shestakova MV, Gerasimenko OI, Zverev KV, Rogov VA, et al. The antiproteinuric action of angiotensin-converting enzyme inhibitors in chronic glomerulonephritis and diabetic nephropathy [in Russian]. Ter Arkh. 1994;66:19-22.
4. Liou HH, Huang TP, Campese VM. Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin-dependent diabetes and with non-diabetic renal disease. Nephron. 1995;69:41-8.
5. Rostoker G, Ben Maadi A, Remy P, Lagrue G, Weil B. Low-dose angiotensin-converting enzyme inhibitor captopril to reduce proteinuria in adult idiopathic membranous nephropathy: A prospective study of long-term treatment. Nephrol Dial Transplant. 1995;10:25-9.
6. Ravid M, Lang R, Rachmani R, Lishner M. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. Arch Intern Med. 1996;156:286-9.
7. Cattran DC, Greenwood C, Ritchie S. Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin a nephropathy: A comparison to patients receiving treatment with other antihypertensive agents and to patients receiving to therapy. Am J Kidney Dis. 1994;23:247-54.
8. Omata K, Kanazawa M, Sato T, Abe F, Saito T, Abe K. Therapeutic advantages of angiotensin converting enzyme inhibitors in chronic renal disease. Kidney Int. 1996; 55(Suppl):S57-62.
9. Ito S, Abe K. Influence of anti-hypertensive drugs on glomerular hemodynamics. Nippon Jinzo Gakkai Shi. 1996;38:115-8.
10. Stratta P, Canvese C, Dogliani M, Mazzucco G, Monga G, Vercellone A, et al. The role of free radicals in the progression of renal disease. Am J Kidney Dis. 1991; 17(suppl):33-7.
11. Shav SV. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int. 1989;35:1093-1106.
12. Chopra M, Beswick H, Clapperton M, Dargie HJ, Smith WE, McMurray J. Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: Free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors. J Cardiovasc Pharmacol. 1992;19:330-40.
13. Westlin W, Mullane K. Does captopril attenuate reperfusion induced myocardial dysfunction by scavenging free radicals? Circulation. 1988;77(suppl 1):I-130-9.
14. Stasch JP, Hirth-Dietrich C, Frobel K, Wegner M. Prolonged endothelin blockade reduces hypertension and cardiac hypertrophy in SHR-SP. J Cardiovasc Pharmacol. 1995; 26(suppl 3):S436-8.
15. Barone FC, Nelson AH, Ohlstein EH, Willette RN, Sealey JE, Laragh JH, et al. Chronic carvedilol reduces morbidity and renal damage in hypertensive stroke-prone rats. J Pharmacol Exp Ther. 1996;279:948-55.
16. Grunfeld S, Hamilton CA, Mesaros S, McClain SW, Dominiczak AF, Bohr DF, et al. Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension. 1995;26(pt 1):854-7.
17. Koike H, Yanagisawa H, Ikeda T, Manabe S, Ishikawa S, Kawahara Y. Temocapril(CS-622), a novel angiotensin converting enzyme inhibitor. Ann Rep Sankyo Res Lab. 1992; 44:1-81.
18. Wang LN, Fukui M, Shou I, Yaguchi Y, Funabiki K, Horikoshi S, et al. Detection of antioxidant enzyme activities in renal tissues of early stage IgA nephropathy in ddY mice. J Clin Lab Anal. 1996;10:394-8.
19. Noto A, Ogawa Y, Mori S, Yoshioka M, Kitakaze T, Hori T, et al. Simple, rapid spectrophotometry of urinary N-acetyl-β D-glucosaminidase, with use of a new chromogenic substrate. Clin Chem. 1983;29:1713-6.
20. Glenn R, Cohen MP. Improved competitive enzyme linked immunoassay (ELISA) for albuminuria. Clin Chim Acta. 1989;179:229-38.
21. Oyanagi Y. Reevaluation of assay methods and establishment of kit for superoxide dismutase activity. Anal Biochem. 1984;142:290-6.
22. Flohe L, Gunzler WA. Assays of glutathione peroxidase. In: Packer L; ed. Method in Enzymology, vol 105. Oxygen Radicals in Biological Systems. London: Academic Press, Inc., Ltd.; 1984:114-21.
23. Aebi HE. Catalase. In: Bermeyer HU; ed. Methods in Enzyme Analysis, 3rd ed., vol III. Weinheim: Verlag Chemie; 1982: 273-82.
24. Yokoyama K, Sei C, Tomino Y, Koide H, Yamakura H, Ohmori D. Detection of serum SOD activity using ESR in patients with chronic glomerulonephritis and chronic renal failure. In: Tomino Y, Ohwada S, Ito S, et al; eds. Kidney and Free Radical in Kidney and Dialysis [in Japanese]. Tokyo: Tokyo Igakusha; 1994:205-7.
25. Tang Z, Shou I, Wang LN, Fukui M, Tomino Y. Effects of antihypertensive drugs or glycemic control on antioxidant enzyme activities in spontaneously hypertensive rats (SHR) with diabetes. Nephron. 1997;76:323-30.
26. Asayama K, Shiki Y, Ito H, Hasegawa O, Miyao A, Hayashibe H, et al. Antioxidant enzymes in blood in uremic children and adolescents. Free Radic Biol Med. 1990;9(2): 105-9.
27. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev. 1979;59:527-605.
28. Omata M. Role of reactive oxygen species (ROS) in model immune complex nephritis [in Japanese]. Jpn J Nephrol. 1990;32:949-58. English abstract.
29. Yoshioka T, Bills T, Moore-Jarrett T, Greene HL, Burr TM, Ichiawa I. Role of intrinsic antioxidant enzymes in renal oxidant injury. Kidney Int. 1990;38:282-8.
30. de Cavanagh EMV , Inserra F, Ferder L, Romano L, Ercole L, Fraga CG. Superoxide dismutase and glutathione peroxidase activities are increased by enalapril and captopril in mouse liver. FEBS Lett. 1995;361:22-4.
31. Singh I, Gulati S, Orak JK, Singh AK. Expression of antioxidant enzymes in rat kidney during ischemia-reperfusion injury. Mol Cell Biochem. 1993;125:97-104.
32. Sarkar S, Yadav P, Trivedi R, Bansal AK, Bhatnagar D. Cadmium-induced lipid peroxidation and the status of the antioxidant system in rat tissues. J Trace Elem Med Biol. 1995;9:144-9.
33. Muse KE, Sempf JM, Oberley LW. Immunolocalization of antioxidant enzymes in adult hamster kidney. Histochem J. 1994;26:734-53.
34. Kiyama S, Yoshioka T, Burr IM, Kon V, Fago A, Ichikawa I. Strategic locus for the activation of the superoxide dismutase gene in the nephron. Kidney Int. 1995;47:536-46.
35. Ghosh B, Hanevold CD, Dobashi K, Orak JK, Singh I. Tissue differences in antioxidant enzyme gene expression in response to endotoxin. Free Radic Biol Med. 1996;21:33-40.
36. Nishimura H, Sanaka T, Nihei H, Nishikawa M, Aikawa M. Mechanism of elevated local antioxidant stress in early anti-glomerular basement membrane nephritis: An evaluation of oxidant production and superoxide dismutase expression. Nippon Jinzo Gakkai Shi. 1996;38:441-8.
37. Cooper ME, Rumble CJ, Allen TJ, O'Brien RD, Jermus G, Doyle AE. Antihypertensive therapy in a model combining spontaneous hypertension with diabetes. Kidney Int. 1992;41:898-903.
38. Hirawa N, Uehara Y, Kawabata Y, Oshima N, Ono H, Nagata T, et al. Mechanistic analysis of renal protection by angiotensin converting enzyme inhibitors in Dahl salt-sensitive rats. J Hypertens. 1994;12:909-18.